Zotefoams plc (LON:ZTF - Get Free Report) insider Ronan Cox acquired 48 shares of Zotefoams stock in a transaction that occurred on Friday, July 11th. The stock was acquired at an average cost of GBX 316 ($4.24) per share, with a total value of £151.68 ($203.54).
Ronan Cox also recently made the following trade(s):
- On Wednesday, June 11th, Ronan Cox acquired 44 shares of Zotefoams stock. The stock was acquired at an average cost of GBX 336 ($4.51) per share, with a total value of £147.84 ($198.39).
- On Monday, May 12th, Ronan Cox acquired 58 shares of Zotefoams stock. The stock was acquired at an average cost of GBX 261 ($3.50) per share, with a total value of £151.38 ($203.14).
Zotefoams Stock Up 1.3%
Shares of ZTF stock traded up GBX 4 ($0.05) during trading hours on Thursday, reaching GBX 318 ($4.27). 40,293 shares of the company's stock were exchanged, compared to its average volume of 109,384. The stock's 50 day moving average is GBX 303.24 and its 200-day moving average is GBX 287.80. The company has a market cap of £152.95 million, a price-to-earnings ratio of 15.40, a P/E/G ratio of 0.66 and a beta of 1.40. The company has a current ratio of 1.30, a quick ratio of 0.67 and a debt-to-equity ratio of 42.07. Zotefoams plc has a fifty-two week low of GBX 222 ($2.98) and a fifty-two week high of GBX 536 ($7.19).
About Zotefoams
(
Get Free Report)
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Featured Stories

Before you consider Zotefoams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zotefoams wasn't on the list.
While Zotefoams currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.